Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Escherichia coli | penicillin-binding protein | Starlite/ChEMBL | No references |
Homo sapiens | glycoprotein hormones, alpha polypeptide | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Possible penicillin-binding protein | Get druggable targets OG5_149948 | All targets in OG5_149948 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Toxoplasma gondii | intraflagellar transport protein 172, putative | glycoprotein hormones, alpha polypeptide | 116 aa | 94 aa | 26.6 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Papain family cysteine protease containing protein | 0.0275 | 0.3427 | 0.3427 |
Loa Loa (eye worm) | cathepsin B | 0.0187 | 0.1119 | 0.1119 |
Giardia lamblia | Cathepsin B precursor | 0.0187 | 0.1119 | 0.5 |
Schistosoma mansoni | SmCL2-like peptidase (C01 family) | 0.0275 | 0.3427 | 0.2926 |
Loa Loa (eye worm) | hypothetical protein | 0.0372 | 0.5972 | 0.5972 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.0708 | 0.0708 |
Loa Loa (eye worm) | hypothetical protein | 0.0355 | 0.5518 | 0.5518 |
Giardia lamblia | Cathepsin B precursor | 0.0187 | 0.1119 | 0.5 |
Trypanosoma cruzi | cysteine proteinase, putative | 0.0275 | 0.3427 | 0.2926 |
Plasmodium vivax | vivapain-3 | 0.0275 | 0.3427 | 0.2926 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0372 | 0.5972 | 0.5665 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.0708 | 0.0708 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0372 | 0.5972 | 0.5665 |
Loa Loa (eye worm) | hypothetical protein | 0.0355 | 0.5518 | 0.5518 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0355 | 0.5518 | 0.4954 |
Echinococcus multilocularis | cathepsin b | 0.0372 | 0.5972 | 0.3872 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0278 | 0.3497 | 0.5 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0275 | 0.3427 | 0.2599 |
Loa Loa (eye worm) | hypothetical protein | 0.0355 | 0.5518 | 0.5518 |
Echinococcus granulosus | cathepsin b | 0.0372 | 0.5972 | 0.3872 |
Brugia malayi | Papain family cysteine protease containing protein | 0.0275 | 0.3427 | 0.3427 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0355 | 0.5518 | 0.5177 |
Schistosoma mansoni | SmCB2 peptidase (C01 family) | 0.0372 | 0.5972 | 0.5665 |
Schistosoma mansoni | SmCL2-like peptidase (C01 family) | 0.0275 | 0.3427 | 0.2926 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0275 | 0.3427 | 0.2599 |
Echinococcus granulosus | cathepsin b | 0.0372 | 0.5972 | 0.3872 |
Trypanosoma cruzi | cysteine peptidase (N-terminal), putative | 0.0275 | 0.3427 | 0.2926 |
Brugia malayi | Cathepsin L-like cysteine proteinase | 0.0355 | 0.5518 | 0.5518 |
Loa Loa (eye worm) | papain family cysteine protease containing protein | 0.0171 | 0.0708 | 0.0708 |
Giardia lamblia | Cathepsin B precursor | 0.0187 | 0.1119 | 0.5 |
Brugia malayi | Cathepsin L-like precursor | 0.0355 | 0.5518 | 0.5518 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0187 | 0.1119 | 0.0442 |
Trypanosoma cruzi | cysteine peptidase, clan CA, family C1, cathepsin L-like, putative | 0.0355 | 0.5518 | 0.5177 |
Brugia malayi | cathepsin L-like precursor | 0.0355 | 0.5518 | 0.5518 |
Echinococcus multilocularis | cathepsin b | 0.0372 | 0.5972 | 0.3872 |
Plasmodium vivax | unspecified product | 0.0275 | 0.3427 | 0.2926 |
Echinococcus granulosus | cathepsin l1 | 0.0355 | 0.5518 | 0.3182 |
Entamoeba histolytica | cysteine proteinase, putative | 0.0355 | 0.5518 | 0.3182 |
Brugia malayi | cathepsin L-like cysteine proteinase, identical | 0.0171 | 0.0708 | 0.0708 |
Brugia malayi | Cathepsin L-like precursor | 0.0355 | 0.5518 | 0.5518 |
Plasmodium vivax | vivapain-1 | 0.0275 | 0.3427 | 0.2926 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0275 | 0.3427 | 0.2599 |
Brugia malayi | Cathepsin L-like precursor | 0.0171 | 0.0708 | 0.0708 |
Brugia malayi | cathepsin F-like cysteine proteinase | 0.0171 | 0.0708 | 0.0708 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0372 | 0.5972 | 0.5665 |
Trypanosoma cruzi | cysteine peptidase C (CPC), putative | 0.0372 | 0.5972 | 0.5665 |
Trypanosoma cruzi | cysteine proteinase, putative | 0.0275 | 0.3427 | 0.2926 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.0275 | 0.3427 | 0.2926 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.0708 | 0.0708 |
Schistosoma mansoni | SmCL2-like peptidase (C01 family) | 0.0275 | 0.3427 | 0.2926 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C1, Cathepsin L-like | 0.0275 | 0.3427 | 0.2599 |
Brugia malayi | cathepsin B-like cysteine proteinase | 0.0372 | 0.5972 | 0.5972 |
Schistosoma mansoni | cathepsin B-like peptidase (C01 family) | 0.0187 | 0.1119 | 0.0442 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0355 | 0.5518 | 0.4954 |
Trypanosoma cruzi | cysteine protease, putative | 0.0275 | 0.3427 | 0.2926 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 1.4125 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 1.9953 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Potency (functional) | 3.1623 uM | PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.3096 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.